Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenAlex
Works that cite this article, indexed by OpenAlex.
Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy
Blood 133(2) (2018)
Shigeru Kusumoto; Luca Arcaini; Xiaonan Hong; Jie Jin; Won Seog Kim; Yok‐Lam Kwong; Marion G. Peters; Yasuhito Tanaka; Andrew David Zelenetz; Hiroshi Kuriki; Günter Fingerle‐Rowson; Tina G. Nielsen; Eisuke Ueda; Hanna Piper-Lepoutre; Gila Sellam; Kensei Tobinai
Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus
Archives of Dermatological Research 310(2) (2017)
Soheil Tavakolpour
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
PLoS ONE 12(9) (2017)
Marı́a Buti; María Luisa Manzano; Rosa Maria Morillas; Montserrat Garcı́a-Retortillo; Leticia Martín; M. Prieto; María Luisa Gutiérrez García; Emilio Suárez; Mariano Gómez Rubio; Javier López; Pilar Castillo; Manuel Rodríguez; José Manuel Zozaya; Miguel Ángel Simón; Luis Enrique Morano; José Luís Calleja; María Yébenes; Rafael Esteban
Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival
Cancer Science 111(11) (2020)
Shukui Qin; Qing Li; Jian Xu; Jun Liang; Ying Cheng; Ying Fan; Jun Jiang; Hao Ye; Huimin Tao; Lian Li; Limin Zheng; Zhaohui Wei; Shu Li; Kun Meng; Bin Ye; Yan Sun
Liver Illness and Psoriatic Patients
BioMed Research International 2018 (2018)
Marco Fiore; Sebastiano Leone; Alberto Enrico Maraolo; Emilio Berti; Giovanni Battista Damiani
Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections
Blood Reviews 32(5) (2018)
Talal Hilal; Juan Gea‐Banacloche; Jose Francisco Leis
The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence
Cancer Treatment Reviews 86 (2020)
Gonzalo Tapia Rico; Matthew M. K. Chan; Kee Fong Loo
Iranian guideline for rituximab therapy in pemphigus patients
Dermatologic Therapy 32(5) (2019)
Maryam Daneshpazhooh; Kamran Balighi; Hamidreza Mahmoudi; Soheil Tavakolpour; Robabeh Abedini; Tahereh Soori; Amir Houshang Ehsani; Maryam Ghiasi; Pedram Noormohammadpour; Narges Ghandi; Vahide Lajevardi; Ali Sadeghinia; Maryam Nasimi; Arghavan Azizpour; Cheyda Chams‐Davatchi
Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens
World Journal of Gastroenterology 30(44) (2024)
Rui Lu; Meng Zhang; Zi-Han Liu; Miao Hao; Yan Tian; Mei Li; Fengping Wu; Wen-Jun Wang; Juanjuan Shi; Xin Zhang; Xiaoli Jia; Zi-Cheng Jiang; Xuemei Li; Guanghua Xu; Yaping Li; Shuangsuo Dang
Frequency of Hepatitis B Virus infection among Patients before Chemotherapy Treatment
Asian Pacific Journal of Cancer Prevention 22(9) (2021)
Shahab Mahmoudvand; Somaya Shokri; Habibollah Mirzaei; Ali Ramazani; Manoochehr Makvandi; Nilofar Neisi; Sayed Jalal Hashemi
Impact of Hepatitis B Infection on Patient and Graft Survival After Kidney Transplantation
Journal of Clinical Medicine 14(6) (2025)
Anissa Paschereit; Vivien Greese; Kayo Sakurayama; Michael Duerr; Fabian Halleck; Lutz Liefeldt; Mira Choi; Klemens Budde; Marcel Ganesh Naik
Recommendations for the treatment of hepatitis B in 2017
Clinical and Experimental Hepatology 2(2) (2017)
Robert Flisiak; Waldemar Halota; Jerzy Jaroszewicz; Jacek Juszczyk; Piotr Małkowski; Małgorzata Pawłowska; Anna Piekarska; Krzysztof Adam Simon; Krzysztof Tomasiewicz; Marta Wawrzynowicz‐Syczewska
The possible role of interleukin-35 and its therapeutic potential in pemphigus
International Immunopharmacology 42 (2016)
Soheil Tavakolpour; Forough Kheiry; Hajar Sadat Mirsafaei; Meisam Akhlaghdoust
Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences
Expert Opinion on Biological Therapy 17(8) (2017)
Priyanka Vashisht; James R. O’Dell
Manipulation of Regulatory Cells’ Responses to Treatments for Chronic Hepatitis B Virus Infection
Hepatitis Monthly 16(6) (2016)
Soheil Tavakolpour; Seyed Moayed Alavian; Shahnaz Sali
Comparison of Vitamin D Levels in Naive, Treated, and Inactive Carriers with Chronic Hepatitis B Virus
Journal of Clinical and Translational Hepatology 4(4) (2016)
Shahnaz Sali; Soheil Tavakolpour; Baharan Farkhondemehr
SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection
Journal of Clinical Virology Plus 3(4) (2023)
Shahrzad Shoraka; Seyed Reza Mohebbi; Seyed Masoud Hosseini; Amir Ghaemi; Mohammad Reza Zali
Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19
Pathogens 11(5) (2022)
Caterina Sagnelli; Antonello Sica; Massimiliano Creta; Alessândra Borsetti; Massimo Ciccozzi; Evangelista Sagnelli
Hepatitis B reactivation in chronic hepatitis C patients treated with interferon or pan‐oral direct‐acting antivirals
Hepatology 67(1) (2017)
Jiaye Liu
Management of chronic viral hepatitis in the hematological patient
Expert Review of Anti-infective Therapy 16(3) (2018)
Laura Ambra Nicolini; Emanuela Zappulo; Claudio Viscoli; Małgorzata Mikulska
Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy
Immunology Letters 190 (2017)
Soheil Tavakolpour; Hajar Sadat Mirsafaei; Somayeh Elikaei Behjati; Mojtaba Ghasemiadl; Meisam Akhlaghdoust; Shahnaz Sali
Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis
Hepatitis Monthly 16(4) (2016)
Soheil Tavakolpour; Shahnaz Sali
Adoptive immune transfer from donors offers Anti-HBV protection to HBsAb-negative patients after Allo-HSCT
iScience 26(3) (2023)
Jinhua Ren; Qiaoxian Lin; Qi Chen; Jingjing Xu; Dabin Chen; Renli Chen; Kangni Lin; Haojie Zhu; Chenjing Ye; Xiaofeng Luo; Shaozhen Chen; Hui Kong; Qiong Lin; Nan Li; Xu Lin; Zhizhe Chen; Jianda Hu; Ting Yang
Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study
World Journal of Virology 13(1) (2024)
Nayana Sudevan; Manish Manrai; TVSVGK Tilak; Harshit Khurana; Harikrishnan Premdeep
Immune response to occult hepatitis B virus infection among hemodialysis patients: A review
The Microbe 5 (2024)
Ali Mussa; Nor Hayati Ismail; Nazmul Huda Syed; Mustafa Talib; Alaa Siddig; Rosline Hassan; Rohimah Mohamud; Nik Haszroel Hysham Nik Hashim
Risk of HBV reactivation in psoriasis vulgaris patients receiving biological agent therapy
Cutaneous and Ocular Toxicology 44(1) (2025)
Ayşegül Tel Kankılıç; Ömer Karakoyun; Erhan Ayhan
Translating Antiviral Therapies to Veterinary Use: A Review of Immunomodulatory Agents for Potential Application in Aleutian Mink Diseases
Animals 15(16) (2025)
Marcin Kondracki; Andrzej Żmuda; Magdalena Gryzińska; Ilona Mazurkiewicz; Beata Seremak; Jacek Furmaga; A. Jakubczak
The Impact of Different Hepatitis B Virus Serological Statuses on the Safety of Different Chemotherapy Regimens in Female Breast Cancer Patients: A Within-Subject Longitudinal Study
Cancers 17(21) (2025)
Zhao-Xing Li; Dongli Liu; Lei Hu; Bai-qing Peng; Xiu-quan Qu; Li-Yuan Mu; Xiao-Chun Cheng; Pu Qiu; Yu-Xuan Huang; Xirui Li; Lingquan Kong
Management of chronic hepatitis B in special populations
Medical Journal of Viral Hepatitis /Medical Journal of Viral Hepatitis 4.2(2) (2020)
Elsaid Elbadrawy; Zaher Tarik; Eman Mousa; Elshenaway Mostafa; Ahmed Alhawarey; Abdelaziz Mohamed; Hoda Elgamal
Immune phase transition under steroid treatment
Physical review. E 103(6) (2021)
Sonali Priyadarshini Nayak; Susmita Roy
Anti-TNF alfa kullanan hastalarda hepatit B reaktivasyonunun değerlendirilmesi
Dicle Medical Journal / Dicle Tip Dergisi 46(3) (2019)
İlkay Bozkurt; Ahmet Bektaş
Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma
Journal of Investigative Medicine High Impact Case Reports 5(2) (2017)
Alisse Hannaford; David Del Bello; Siyang Leng; Ajai Chari; Ponni Perumalswami; Douglas T. Dieterich; Andrea D. Branch
Tenofovir Alafenamide: A New Drug With Various Ambiguous Aspects in Treatment of Chronic Hepatitis B Infection
Archives of Clinical Infectious Diseases In Press(In Press) (2019)
Soheil Tavakolpour; Mohammad Darvishi; Shahnaz Sali
Durability of Antibody Response Against Hepatitis B Virus for a Decreased Crowd: A Retrospective Polycentric Cohort Study from a 10-Year Follow-Up Clinical Study
Infection and Drug Resistance Volume 15 (2022)
Pei He; Jie Xia; Peixin Zhang; Wensu Yang; Zhaoxin Xia; Ping Liu; Zhu Yi; Yaping Fang; Zhenhua Zhang; Jilu Shen
Anti-Rheumatic Therapy and Comorbidity
Springer eBooks (2017)
John Steuart Richards; Sharon Dowell; Mercedes E. Quiñones
Infectious Complications of Biologics
Springer eBooks (2017)
Renée M. Marchioni Beery; Joshua R. Korzenik
Determination of reactivation rate and risk factors for Hepatitis B virus reactivation in low-positive cases: A retrospective cohort study
Journal of Infection and Chemotherapy 27(10) (2021)
Hitoshi Yonezawa; Shingo Tanaka; Momoko H. Furuya; Kôji Yamada; Koichi Asanuma; Yoshihiro Fujiya; Koji Miyanishi; Satoshi Takahashi; Junji Kato
Marjinal Zon Lenfoma Tanılı Hastalarda Klinik Özellikler ve Olası Prognostik Faktörler: İki Merkezden Retrospektif Analiz
LLM Dergi 6(1) (2022)
Pınar Tığlıoğlu; Abdülkerim Yıldız; Murat Albayrak; Murat Yıldırım; Mesut Tığlıoğlu; Buğra Sağlam; Senem Maral; Hacer Berna Afacan Öztürk; Meltem Aylı; Osman Zikrullah Sahin
Multipl Miyelom ve Lenfomalı Kemoterapi Alan Hastalarda Hepatit B Virüsü Reaktivasyonu ve Aşı Başarısı ile İlişkili Faktörler
LLM Dergi 7(1) (2023)
Ayşe Nilgün Kul; Esra Turan Erkek; Meliha Nalçacı
Prevalence and serological profile of occult hepatitis B virus infection in newly diagnosed cancer patients
Indian Journal of Medical Microbiology 63 (2026)
Subhashree Sahu; Shilpee Kumar; Deepthi Nair